Loading...
OTCM
POSC
Market cap18mUSD
Dec 05, Last price  
1.31USD
1D
-3.46%
1Q
-16.56%
Jan 2017
6,450.00%
Name

Positron Corp

Chart & Performance

D1W1MN
OTCM:POSC chart
P/E
P/S
31.83
EPS
Div Yield, %
Shrs. gr., 5y
18.80%
Rev. gr., 5y
-5.46%
Revenues
588k
-20.03%
4,682,0005,068,0002,780,000762,0002,213,0003,309,0002,126,0001,446,0004,623,0006,663,0002,801,0001,630,0001,466,0001,445,857777,957823,745881,951727,583734,666587,500
Net income
-2m
L+45.73%
-2,967,000892,000-1,658,000-3,806,000-6,586,000-7,780,000-8,975,000-5,749,000-10,923,000-6,121,000-7,955,000-7,104,000-2,584,00012,555-20,752-62,071-595,075-2,859,007-1,638,703-2,388,091
CFO
-2m
L+8.47%
-469,000-74,000-1,293,000-2,208,000-1,613,000-3,500,000-3,407,000-3,345,000-4,687,000-4,075,000-2,240,000-3,046,000-2,415,00095,643-2,568-104,995-616,286-2,542,755-1,595,683-1,730,862

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
IPO date
Feb 10, 1994
Employees
19
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT